Analysts Set Bruker Corporation (NASDAQ:BRKR) Target Price at $57.00

Shares of Bruker Corporation (NASDAQ:BRKR) have been assigned an average recommendation of “Hold” from the fourteen analysts that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $57.00.

Several equities analysts recently weighed in on the stock. Zacks Research downgraded shares of Bruker from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 2nd. Weiss Ratings restated a “sell (d+)” rating on shares of Bruker in a research note on Monday, August 31st. Leerink Partners raised their price objective on shares of Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 7th. Guggenheim raised their price target on shares of Bruker from $50.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, June 29th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Bruker from $55.00 to $65.00 and gave the company an “overweight” rating in a report on Monday, June 8th.

Insiders Place Their Bets

In other news, VP Mark Munch sold 2,000 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total value of $105,740.00. Following the completion of the sale, the vice president owned 134,806 shares of the company’s stock, valued at $7,127,193.22. This represents a 1.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 27.20% of the company’s stock.

Institutional Trading of Bruker

Several hedge funds have recently made changes to their positions in BRKR. Pallas Capital Advisors LLC acquired a new position in shares of Bruker during the 2nd quarter valued at about $570,746,000. Edmond DE Rothschild Holding S.A. acquired a new position in Bruker in the second quarter valued at $169,899,000. Franklin Resources Inc. grew its position in Bruker by 317.7% during the fourth quarter. Franklin Resources Inc. now owns 2,309,404 shares of the medical research company’s stock valued at $108,796,000 after acquiring an additional 1,756,460 shares during the period. Primecap Management Co. CA acquired a new stake in Bruker during the second quarter worth about $53,145,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Bruker in the 2nd quarter worth about $44,839,000. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Price Performance

Shares of NASDAQ BRKR opened at $61.39 on Monday. The company has a market cap of $9.35 billion, a PE ratio of -87.70, a P/E/G ratio of 1.88 and a beta of 1.26. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.92 and a current ratio of 1.85. The business has a 50-day simple moving average of $58.17 and a two-hundred day simple moving average of $49.97. Bruker has a fifty-two week low of $30.09 and a fifty-two week high of $65.30.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. The business had revenue of $838.50 million for the quarter, compared to analyst estimates of $853.57 million. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. Bruker’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, equities analysts expect that Bruker will post 2.12 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, September 21st. Bruker’s dividend payout ratio is currently -28.57%.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.